New screening technique could accelerate and improve mRNA therapies georgiatech NatureNano
We thank K. Tiegren for copyediting the manuscript. Funding was provided by the National Institutes of Health and R01DE026941 ).Authors and Affiliations
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA Curtis Dobrowolski, Kalina Paunovska, Elisa Schrader Echeverri, David Loughrey, Huanzhen Ni, Marine Z. C. Hatit, Melissa P. Lokugamage, Hannah E. Peck, Philip J. Santangelo & James E. Dahlman
Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USADepartment of Chemical Engineering, Georgia Institute of Technology, Atlanta, GA, USAWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Scientists gene-hack human cells to turn invisibleThe cells fully integrated the genes that let squids turn translucent.
Consulte Mais informação »
These cancer cells wake up when people sleepResearchers make ‘striking’ discovery that breast cancer cells are more likely to jump into the blood when people are resting.
Consulte Mais informação »
Man wakes up to find robbery suspects in his southwest Houston apartment, police sayThe victim told police that the four suspects forced him to unlock his cell phone and transfer money from his account to theirs via a money transfer app.
Consulte Mais informação »
Chicago police officer injured when rowdy crowd targets squad car in Portage ParkCell phone video taken early on Sunday shows a group of people kicking and chasing squad cars on North Milwaukee Avenue.
Consulte Mais informação »
Immunotherapy Combos Up Survival in Renal Cell CarcinomaReal-world data from a preprint study confirm phase 3 results showing an OS benefit when immunotherapy is added to tyrosine kinase inhibitors and for immunotherapy-based combinations to treat metastatic renal cell carcinoma. rccsm
Consulte Mais informação »